Neurodegenerative management is evolving through the recognition of biological variables. Recent evidence highlights significant sex differences in Huntington's disease (HD) that impact clinical manifestation and genetic inheritance. This scoping review summarizes findings across multiple domains, offering a clearer picture for clinicians and caregivers seeking to optimize patient care.

Genetic studies indicate that cytosine-adenine-guanine (CAG) repeat lengths are generally similar between sexes when the parent-of-origin is not considered. However, paternal transmission consistently links to repeat expansion and earlier disease onset. Consequently, family history analysis must account for the father’s role in transmission. This pattern underscores why some patients present with symptoms much earlier than their parents did.

Understanding Sex Differences in Huntington's Disease Symptoms

Clinical symptoms diverge significantly based on biological sex. For instance, women frequently struggle with higher rates of depression and irritability. They also tend to experience more severe functional impairment throughout the disease course. Conversely, men more often exhibit apathy and issues related to substance misuse. Furthermore, treatment patterns vary accordingly. Women are more likely to receive antidepressants and anxiolytics, while clinicians prescribe antipsychotics more frequently for men.

Biomarker research provides additional clues into these biological disparities. Studies have identified potential sex-related variations in body composition, neuroimaging, and hormonal profiles. Although these findings remain heterogeneous and exploratory, they suggest that men and women may have unique biological signatures. Therefore, future diagnostic and monitoring tools might require sex-specific calibration to improve clinical accuracy.

In conclusion, biological sex plays a pivotal role in the progression and treatment of HD. Recognizing these differences allows for more precise and personalized management strategies. Medical professionals should integrate this knowledge into their daily practice to support both male and female patients effectively.

How do psychiatric symptoms differ between men and women in HD?

Women with HD are more prone to depression and irritability, while men more commonly exhibit apathy and behaviors related to substance misuse.

Does biological sex influence the age of disease onset?

While CAG repeat lengths are similar across sexes, paternal transmission is consistently linked to repeat expansion, which often results in an earlier age of onset for the offspring.

Why are medication patterns different for men and women with HD?

Medication use typically reflects the prevalence of specific symptoms; women are often prescribed more antidepressants for mood disturbances, whereas men receive more antipsychotics for behavioral management.

Disclaimer: This content is for informational and educational purposes only and does not constitute professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.

References

1. Hemicker G et al. Sex-related differences in Huntington's disease: a scoping review. Biol Sex Differ. 2026 Apr 03. doi: 10.1186/s13293-026-00895-9. PMID: 41933422.
2. Hemicker G et al. Bridging the gap: sex-specific differences in Huntington's disease. Orphanet J Rare Dis. 2026 Jan 10. doi: 10.1186/s13023-025-04184-3.
3. Frontiers in Neuroscience. Sex differences in Huntington's disease from a neuroinflammation perspective. 2024 Jun 09. doi: 10.3389/fnins.2024.1384501.